Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)
UNAVAILABLESun Pharmaceutical Industries, Inc.
Reason: Discontinuation of the manufacture of the drug
Currently not marketed
Updated Aug 5, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)
UNAVAILABLESun Pharmaceutical Industries, Inc.
Reason: Discontinuation of the manufacture of the drug
Currently not marketed
Updated Aug 5, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)
UNAVAILABLESun Pharmaceutical Industries, Inc.
Reason: Discontinuation of the manufacture of the drug
Currently not marketed
Updated Aug 5, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)
UNAVAILABLESun Pharmaceutical Industries, Inc.
Reason: Discontinuation of the manufacture of the drug
Currently not marketed
Updated Aug 5, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)
LIMITEDTeva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: TBD
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)
LIMITEDTrigen Laboratories, LLC
Reason: Demand increase for the drug
Allocation to current contracted customers
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)
LIMITEDTrigen Laboratories, LLC
Reason: Demand increase for the drug
Allocation to current contracted customers
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)
LIMITEDTrigen Laboratories, LLC
Reason: Demand increase for the drug
Allocation to current contracted customers
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)
LIMITEDTrigen Laboratories, LLC
Reason: Demand increase for the drug
Allocation to current contracted customers
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)
LIMITEDTrigen Laboratories, LLC
Reason: Demand increase for the drug
Allocation to current contracted customers
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)
LIMITEDTrigen Laboratories, LLC
Reason: Demand increase for the drug
Allocation to current contracted customers
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)
LIMITEDTrigen Laboratories, LLC
Reason: Demand increase for the drug
Allocation to current contracted customers
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)
AVAILABLETeva Pharmaceuticals USA, Inc.
Updated Aug 4, 2026
Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)
AVAILABLEJanssen Pharmaceuticals
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)
AVAILABLETeva Pharmaceuticals USA, Inc.
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)
AVAILABLELannett Company, Inc.
Updated Aug 4, 2026
Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)
AVAILABLEJanssen Pharmaceuticals
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37)
AVAILABLELannett Company, Inc.
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)
AVAILABLETeva Pharmaceuticals USA, Inc.
Updated Aug 4, 2026
Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)
AVAILABLEJanssen Pharmaceuticals
Updated Aug 4, 2026
Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)
AVAILABLEJanssen Pharmaceuticals
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37)
AVAILABLELannett Company, Inc.
Updated Aug 4, 2026
Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37)
AVAILABLELannett Company, Inc.
Updated Aug 4, 2026
Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30)
AVAILABLEVertical Pharmaceuticals, LLC
Updated Jul 15, 2026
FindRx is a medication availability service — we track which pharmacies have products in stock and route you to them. We are not a pharmacy, we don't sell or dispense medication, and nothing on this page is medical advice. Shortage details come from the FDA Drug Shortages list and manufacturer updates; local stock changes hour to hour, so confirm with the pharmacy at pickup. Questions about whether a medication is right for you belong with your prescriber or pharmacist.